Physician profile
Jin Lee
NPI 1639349111
$2,060.44
in general payments reported to CMS, 2019-2025
21 companies · $783 in 2025
The $783 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $53.00 · 2021: $117 · 2022: $45.96 · 2023: $77.48 · 2024: $763 · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,623.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $227.73 | 2024-2025 | Adbry |
| Incyte Corporation | $210.12 | 2023-2025 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $201.72 | 2019 | |
| Janssen Biotech, INC. | $200.00 | 2023-2025 | Tremfya |
| Ucb, INC. | $194.47 | 2024-2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $173.52 | 2019-2024 | Winlevi |
| Regeneron Healthcare Solutions, INC. | $138.37 | 2024-2025 | Dupixent |
| Abbott Laboratories | $116.67 | 2021 | |
| Amgen INC. | $81.26 | 2024-2025 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $73.38 | 2024 | Sotyktu |
| Genzyme Corporation | $70.66 | 2024-2025 | |
| Dermavant Sciences, INC. | $67.62 | 2024 | Vtama |
| Pfizer INC. | $66.77 | 2022-2024 | |
| Arcutis Biotherapeutics, INC. | $63.89 | 2025 | Zoryve |
| Vyne Pharmaceuticals INC. | $53.00 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.57 | 2025 | Spevigo |
| Galderma Laboratories, L.P. | $25.17 | 2025 | Aklief |
| Almirall LLC | $21.86 | 2025 | Klisyri |
| Strata Skin Sciences, INC. | $16.33 | 2025 | Xtrac |
| Abbvie INC. | $15.74 | 2025 | |
| Medline Industries LP | $15.59 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.